Company: ORBS
Filing Date: 2025-09-11
Form Type: S-3ASR
Source: 0001493152-25-013022
Chunk: 48

Company: Eightco Holdings Inc.
Filing Date: 2025-09-11
Form: S-3ASR
Chunk 48
---
 prospectus.

Sales of our Common Stock, if any, under this prospectus may be made in sales deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “ Securities Act”). Subject to the terms of the Sales Agreement, Lafferty is not required to sell any specific number or dollar amounts of our Common Stock but will use commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Lafferty and us. There is no current arrangement for funds to be received in any escrow, trust or similar arrangement.

The Agent will be entitled to compensation under the terms of the Sales Agreement at a commission rate of up to 3.0% of the gross proceeds from each sale of our Common Stock. In connection with the sales of our Common Stock on our behalf, the Agent will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of the Agent will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contributions to the Agent against certain liabilities, including liabilities under the Securities Act and the Securities Exchange Act of 1934, as amended (the “ Exchange Act”).

As of the date of this prospectus, our Common Stock trades on the Nasdaq Capital Market LLC (“Nasdaq”) under the symbol “OCTO”; however, the trading symbol of the Company’s Common Stock is expected to change to “ORBS”, effective as of the opening of trading on September 11, 2025.

On September 9, 2025, the last reported sale price of our Common Stock on the Nasdaq was $40.17 per share.

Investing in our Common Stock involves significant risks. See “Risk Factors” beginning on page S-12 of this prospectus and the risk factors that are incorporated by reference into this prospectus from our filings made with the Securities and Exchange Commission (the “ SEC”) pursuant to the Exchange Act for a discussion of the factors you should carefully consider before deciding to invest in our Common Stock.

Neither the SEC nor any state securities commission has approved or disapproved of our Common Stock or determined if this prospectus is accurate, truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is September 10, 2025.</div>

<div align='center'>TABLE OF CONTENTS

Pros